Author

P Rys

Observed names: P. Rys, Przemyslaw M Rys, Przemyslaw Rys, Przemysław Rys, Przemysław Ryś

Observed institution: Muzeum Krakowa

ORCID: 0009-0007-0513-7750

Observed ORCID: 0009-0007-0513-7750

OpenAlex ID: A5044468185

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis

2012 · P. Wojciechowski, A. Lipowska, et al. · Diabetologia · 107

PDF

Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus

2015 · Przemyslaw Rys, Piotr Wojciechowski, et al. · Acta Diabetologica · 101

PDF

Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies

2018 · Przemyslaw M Rys, Agnieszka H Ludwig-Slomczynska, et al. · European Journal of Endocrinology · 90

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review

2011 · P. Rys, O. Pankiewicz, et al. · Diabetes & Metabolism · 64

Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes. Systematic review and meta-analysis

2011 · Piotr Wojciechowski, Przemysław Ryś, et al. · Polskie Archiwum Medycyny Wewnętrznej · 43

PDF

The Role of Surrogate Endpoints in the Evaluation of Efficacy and Safety of Therapeutic Interventions in Diabetes Mellitus

2008 · Aleksandra Wieczorek, Przemyslaw Rys, et al. · The Review of Diabetic Studies · 28

PDF

Review articles, systematic reviews and meta‑analyses: which can be trusted?

2009 · Przemysław Ryś, Magdalena Władysiuk, et al. · Polskie Archiwum Medycyny Wewnętrznej · 27

Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis

2024 · Julia K. Mader, Ricardo Fornengo, et al. · Diabetes Technology & Therapeutics · 25

NPWT in diabetic foot wounds—a systematic review and meta-analysis of observational studies

2020 · Przemyslaw Rys, Sebastian Borys, et al. · Endocrine · 24

Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis

2016 · Marek L. Kowalski, Piotr Wojciechowski, et al. · Allergy and Asthma Proceedings · 24

Pancreatic Enzyme Replacement Therapy in Pancreatic Exocrine Insufficiency—Real-World’s Dosing and Effectiveness: A Systematic Review

2025 · Roland Kadaj-Lipka, Magdalena Monica, et al. · Digestive Diseases and Sciences · 19

Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis

2015 · Piotr Wojciechowski, Patrycja Niemczyk-Szechowska, et al. · Polskie Archiwum Medycyny Wewnętrznej · 14

PDF

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus - a systematic review and meta-analysis

2014 · P. Rys, P. Wojciechowski, et al. · International Journal of Clinical Practice · 14

Epidemiology of diabetes in Poland in 2014–2017

2020 · Iwona Towpik, Magdalena Walicka, et al. · Clinical Diabetology · 13

PDF

Risk factors for Lipohypertrophy in People With Insulin-Treated Diabetes: A Systematic Meta-Analysis

2025 · Julia K. Mader, Riccardo Fornengo, et al. · Journal of Diabetes Science and Technology · 8

Economic analysis of the implementation of guidelines for type 2 diabetes control developed by Diabetes Poland. What increase in costs is justified by clinical results?

2011 · Daria Szmurło, Agata Schubert, et al. · Polskie Archiwum Medycyny Wewnętrznej · 6

PDF

Cost-utility analysis for insulin aspart and biphasic insulin aspart in treatment of type 1 and 2 diabetes mellitus

2010 · D. Szmurlo, Marcin Hetna, et al. · Via Medica Journals · 3

PDF

Existing Knowledge Gaps in Risk Factors and Consequences of Lipohypertrophy in People Using Continuous Subcutaneous Insulin Infusion Therapy: A Systematic Review and Meta-analysis

2025 · Julia K. Mader, Riccardo Fornengo, et al. · Journal of Diabetes Science and Technology · 2

PDF

Epidemiologia cukrzycy w Polsce w latach 2014–2017

2020 · Iwona Towpik, Magdalena Walicka, et al. · Diabetologia Praktyczna · 2

PMH34 Cost-Utility of Amisulpride Compared with First Generation Antipsychotics in Treatment of Schizophrenia in Poland

2011 · K. Kostrzewska, J. Lis, et al. · Value in Health · 2

Relationship between lipohypertrophy, glycemic control, and insulin dosing: a systematic meta-analysis

2024 · Julia K. Mader, Ricardo Fornengo, et al. · Diabetologie und Stoffwechsel · 1

Pcn120 Cost-utility of Docetaxel Compared With Best Supportive Care and Pemetrexed in Second Line Treatment of Non-small Cell Lung Cancer in Poland

2009 · J Rutkowski, B Gwiosda, et al. · Value in Health · 1

Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes mellitus receiving prandial insulin regimen - a systematic review and meta-analysis

2014 · P. Wojciechowski, P. Niemczyk-Szechowska, et al. · Value in Health

A comparison of biphasic insulin aspart (biasp30) with biphasic human insulin (bhi30) for type 2 diabetes mellitus in real clinical practice – A systematic review and meta-analysis

2013 · P Wojciechowski, M Gaweska, et al. · Value in Health

PIN1 Efficacy and Safety of Tenofovir as Compared With Alternative Treatment Options for Naive Chronic Hepatitis B – a Systematic Review and Mixed Treatment Comparison

2012 · J. Skarzynska-Duk, A. Stozek, et al. · Value in Health

Works count: 63

Citation count: 618

H-index: 13

I10-index: 14